Abstract:Purpose: Combining siRNA and other chemotherapeutic agents into one nanocarrier can overcome the multidrug resistance (MDR) phenomenon by synergistically MDR relative genes silencing and elevated chemotherapeutic activity. Most of these systems are typically fabricated through complicated procedures, which involves materials preparation, drug loading and modifications. Herein, the purpose of this study is to develop a new and fast co-delivery system of siRNA and doxorubicin for potentially synergistic cancer treatment. Methods: The co-delivery system is constructed conveniently by a stable complex consisting of doxorubicin bound to siRNA via intercalation firstly, followed by interacting with (3-Aminopropyl)triethoxysilane (APTES) electrostatically and Tetraethyl orthosilicate (TEOS) co-condensed, and the characterizations of the resultant nanocarrier are also investigated. Furthermore, this study evaluates the synergistic anti-cancer efficacy in MCF-7/MDR cells after treatment of siRNA and doxorubicin 'two in one' nanocarriers. Results: We establish a new and fast method to craft a co-delivery system of siRNA and doxorubicin with controllable and nearly uniform size, and the entire fabrication process only costs in about 10 minutes. The resultant co-delivery system presents high loading capacities of siRNA and doxorubicin, and the encapsulated doxorubicin plays a pH-responsive control release. Further, biological functionality tests of the synthesized co-delivery nanocarriers show high inhibition of P-gp protein encoded by MDR-1 gene in MCF-7/MDR cells (a variant of human breast cancer cell line with drug resistance) after transfection of these nanocarriers carrying MDR-1 siRNA and doxorubicin simultaneously, which sensitize the MCF-7/MDR cells to doxorubicin, overall leading to improved cell suppression. Conclusion: Collectively, this co-delivery system not only serves as potent therapeutics for synergistic cancer therapy, it also may facilitate the bench-to-bedside translation of combinatorial delivery system as a robust drug nanocarrier by allowing for fabricating a simply and fast nanocarrier for co-delivery of siRNA and doxorubicin with predictable high production rate.

A Sirna-Induced Peptide Co-Assembly System As a Peptide-Based Sirna Nanocarrier for Cancer Therapy

Biocompatible, Chimeric Peptide-Condensed Supramolecular Nanoparticles for Tumor Cell-Specific Sirna Delivery and Gene Silencing.

Peptide-Aptamer Coassembly Nanocarrier for Cancer Therapy.

A Mesoporous Silica Nanoparticle--pei--fusogenic Peptide System for Sirna Delivery in Cancer Therapy.

The Sirnasome: A Cation‐Free and Versatile Nanostructure for Sirna and Drug Co‐delivery

Smart Nanoparticles Assembled by Endogenous Molecules for Sirna Delivery and Cancer Therapy Via CD44 and EGFR Dual-Targeting

Artificial Nucleobase-Directed Programmable Synthesis and Assembly of Amphiphilic Nucleic Acids As an All-in-One Platform for Cation-Free Sirna Delivery.

Adaptive Amphiphilic Dendrimer‐Based Nanoassemblies As Robust and Versatile Sirna Delivery Systems

A Hybrid Nanoassembly for Ultrasound-Inducible Cytosolic Sirna Delivery and Cancer Sono-Gene Therapy.

In Vitro and in Vivo Therapeutic Sirna Delivery Induced by a Tryptophan-Rich Endosomolytic Peptide

Nanoparticle‐Mediated Sirna Delivery and Multifunctional Modification Strategies for Effective Cancer Therapy

Precise Assembly of Synthetic Carriers of Sirna Through a Series of Interlocked Thermodynamically Self‐Regulated Processes

Biodegradable Stearylated Peptide with Internal Disulfide Bonds for Efficient Delivery of Sirna in Vitro and in Vivo.

Recent Advances in Sirna Delivery for Cancer Therapy Using Smart Nanocarriers

Quick Synthesis of a Novel Combinatorial Delivery System of Sirna and Doxorubicin for a Synergistic Anticancer Effect

A Nanoplatform Self-Assembled by Coordination Delivers Sirna for Lung Cancer Therapy

Delivery Systems for Sirna Drug Development in Cancer Therapy

Self-assembly Nanomicelles Based on Cationic Mpeg-Pla-b-polyarginine(r15) Triblock Copolymer for Sirna Delivery.

A Crosslinked Nucleic Acid Nanogel for Effective Sirna Delivery and Antitumor Therapy

Ph-Responsive Complexes Using Prefunctionalized Polymers for Synchronous Delivery of Doxorubicin and Sirna to Cancer Cells

Systemic and Tumor-Targeted Delivery of Sirna by Cyclic NGR and Isodgr Motif-Containing Peptides.